Exact Mass: 666.2652442
Exact Mass Matches: 666.2652442
Found 20 metabolites which its exact mass value is equals to given mass value 666.2652442,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Darapladib
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].
[(2R,3S,4S,5R,6R)-6-[1,7-bis(4-hydroxyphenyl)-5-oxoheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
trichagmalin A
A limonoid with a phragmalin skeleton isolated from the leaves of Trichilia connaroides.
13-de-O-acetylspicachlorantin E|chlorajaponilide E
[(2R,3S,4S,5R,6R)-6-[1,7-bis(4-hydroxyphenyl)-5-oxoheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
1,7-Bis(4-hydroxyphenyl)-5-oxo-3-heptanyl 6-O-[(2E)-3-(3,4-dimethoxyphenyl)-2-propenoyl]-?-D-glucopyranoside
(3AR,4R,5R,6AS)-4-((R,E)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)-4-(3-(TRIFLUOROMETHYL)PHENOXY)BUT-1-EN-1-YL)-2-OXOHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-5-YL [1,1-BIPHENYL]-4-CARBOXYLATE
C37H41F3O6Si (666.2624362000001)
Darapladib
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].
chlorajaponilide E, (rel)-
A natural product found in Chloranthus japonicus.
6-[2-(2,4-dihydroxyphenyl)-3-[(2Z)-3,7-dimethylocta-2,6-dienyl]-7-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-6,7-dihydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-2-yl]-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[2-(2,4-dihydroxyphenyl)-3-[(2Z)-4-hydroxy-3,7-dimethylocta-2,6-dienyl]-8-(3-methylbut-2-enyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
7-hydroxy-12-{7-hydroxy-8-methoxy-18-oxo-5-propanoyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9,20-tetraen-9-yl}-5,15-diazatetracyclo[10.3.1.0¹,⁵.0⁶,¹¹]hexadeca-6,8,10-triene-4,16-dione
C37H38N4O8 (666.2689508000001)
(1s,12r)-7-hydroxy-12-[(1r,4r,12r,16s)-7-hydroxy-8-methoxy-18-oxo-5-propanoyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9,20-tetraen-9-yl]-5,15-diazatetracyclo[10.3.1.0¹,⁵.0⁶,¹¹]hexadeca-6,8,10-triene-4,16-dione
C37H38N4O8 (666.2689508000001)
(1r,12s)-7-hydroxy-12-[(1r,4r,12r,16s)-7-hydroxy-8-methoxy-18-oxo-5-propanoyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9,20-tetraen-9-yl]-5,15-diazatetracyclo[10.3.1.0¹,⁵.0⁶,¹¹]hexadeca-6,8,10-triene-4,16-dione
C37H38N4O8 (666.2689508000001)